| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |